+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Infection Drug"

From
Anti-Infectives - Global Strategic Business Report - Product Thumbnail Image

Anti-Infectives - Global Strategic Business Report

  • Report
  • May 2025
  • 116 Pages
  • Global
From
From
From
Chlamydia Infection Treatment Market Report 2025 - Product Thumbnail Image

Chlamydia Infection Treatment Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
From
Staphylococcal Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Staphylococcal Infections - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
Surgical Wound Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Surgical Wound Infections - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Varicella Zoster (HHV-3) Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Varicella Zoster (HHV-3) Infections - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Scedosporium Infection - Pipeline Insight, 2025 - Product Thumbnail Image

Scedosporium Infection - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Eye Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Eye Infections - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Sternal Wound Infection - Pipeline Insight, 2025 - Product Thumbnail Image

Sternal Wound Infection - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Staphylococcus Aureus Infection - Pipeline Insight, 2025 - Product Thumbnail Image

Staphylococcus Aureus Infection - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Chronic Hepatitis B Virus Infection - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Hepatitis B Virus Infection - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 200 Pages
  • Global
From
Hepatitis C Virus Infection- Pipeline Insight, 2025 - Product Thumbnail Image

Hepatitis C Virus Infection- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Pneumococcal Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Pneumococcal Infections - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 75 Pages
  • Global
From
Hepatitis B Virus Infection - Pipeline Insight, 2025 - Product Thumbnail Image

Hepatitis B Virus Infection - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 180 Pages
  • Global
From
From
Loading Indicator

The Infectious Diseases Drugs market is a subset of the pharmaceutical industry that focuses on the development and production of drugs used to treat infectious diseases. These drugs are used to treat a wide range of infections, including bacterial, viral, fungal, and parasitic infections. The market is highly competitive, with many companies vying for market share. Companies in the market are typically focused on developing new drugs, as well as improving existing treatments. Additionally, many companies are involved in the production of generic drugs, which are often cheaper than brand-name drugs. Companies in the Infectious Diseases Drugs market include Pfizer, Merck, GlaxoSmithKline, Sanofi, AstraZeneca, Novartis, Johnson & Johnson, and Bristol-Myers Squibb. Show Less Read more